Veracyte Inc (NAS:VCYT)
$ 31.64 1.22 (4.01%) Market Cap: 2.43 Bil Enterprise Value: 2.12 Bil PE Ratio: 0 PB Ratio: 2.14 GF Score: 83/100

Veracyte Inc at William Blair Growth Stock Conference Transcript

Jun 05, 2019 / 07:00PM GMT
Release Date Price: $24.65 (+5.12%)
Brian David Weinstein
William Blair & Company L.L.C., Research Division - Partner & Healthcare Analyst

All right. We're going to go and get started. Thanks everybody for coming to the afternoon session. There are snacks out back. There are healthy ones and then I have the cookies. So I did not have the healthy ones. But there's all kinds of food, if anybody wants anything. My name is Brian Weinstein and I am the research analyst here at William Blair that covers Veracyte. I cover portions of medical technology and all diagnostics and tools. And we are thrilled to have the management team of Veracyte here with us today.

To give us an update on the business, we have one of my favorite CEOs that I've ever met, Bonnie Anderson. If you haven't met Bonnie, be prepared to be infected with her personality. It is big, it is fun. And just like the business, it's something that you want exposure to. So I should tell you, just by way of formality, to please go to our website, williamblair.com for a list of any potential conflicts or all disclosures. So thank you.

With that, I'll turn it

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot